News
11-02-2019
PulseCath recognized as one of Top 20 Medical Technology solution providing in Europe – 2018
PulseCath Recognized by “MedTech Outlook” Magazin as one of Top 20 Medical Technology solution providing in Europe – 2018 For article Click Here page 46…
10-02-2019
New publication at "Technologische Ontwikkeling"
New publication at “Technologische Ontwikkeling”. Interview with Prof. N. Van Mieghem, Erasmus MC Rotterdam. For full article click here …
10-02-2019
Pulsecath At DGTHG Congress in Wiesbaden, 16 – 19 February 2019
Come and meet with us at DGTHG Congress in Wiesbaden, 16 – 19 February 2019 Location: RheinMain Congress Center Wiesbaden Exhibition Hall 1, Stand C13….
30-10-2018
Meet Us at Dutch Society of Cardiology (NVVC) Autumn Congress Arnhem Nov 2 -2018
Dutch Society of Cardiology (NVVC) Autumn Congress in collaboration with Dutch Association for Thoracic Surgery (NVY) is organized by Dutch Society of Cardiology / Nederlandse Vereniging voor Cardiologie…
30-10-2018
Meet us at Medica- Dusseldorf Germany from 12 – 15 November 2018 Hall 6 stand D27
…
10-10-2018
Meet us at Milan, Italy – 32nd EACTS Annual Meeting, 18-20, October 2018 Stand CO8
Meet us at Milan, Italy – 32nd EACTS Annual Meeting, 18-20, October 2018 Stand CO8 …
14-09-2018
Dr. med. Alexander Samol presents iVAC 2L first German study results at TCT 2018
In 17 patients (3 female, age 73±9 years, left ventricular ejection fraction (LVEF) 45±12%) high-risk PCI (complex left main PCI n=8, PCI of last remaining vessel n=1, complex…
10-06-2018
Ivac 2L got NUB status 1 in Germany
Ivac 2L got reimbursement approval under NUB status 1 in Germany with 78 hospitals around the country…
02-02-2015
Ivac Receives Positive Reimbursement Decision For Hospitals Across Germany
January 30, 2015, the German Institute for the Hospital Remuneration System (InEK) today announced that the iVAC Intra-Aortic Catheter With Para-Corporal Pump for cardiac support of the left…
29-10-2014
Official Commencement of International Multi-Center Clinical Study
The new international multi-center clinical study on the iVAC 3L has officially started in the University Medical Center, Groningen, the Netherlands, and Niguarda Hospital, Milan, Italy with the…
